Glymphatic MRI techniques in sleep and neurodegenerative diseases

Curr Opin Pulm Med. 2022 Nov 1;28(6):499-510. doi: 10.1097/MCP.0000000000000923. Epub 2022 Sep 16.

Abstract

Purpose of review: The purpose of this review article is to summarize the current in-vivo imaging techniques for the evaluation of the glymphatic function and discuss the factors influencing the glymphatic function and research directions in the future.

Recent findings: The glymphatic system allows the clearance of metabolic waste from the central nervous system (CNS). The glymphatic pathway has been investigated using intrathecal or intravenous injection of a gadolinium-based contrast agent (GBCA) on MRI, so-called glymphatic MRI. The glymphatic MRI indirectly visualizes the dynamic CSF flow and evaluated the glymphatic function in the animal and human models. Several clinical and preclinical studies using glymphatic MRI have confirmed that the glymphatic function is impaired in neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and idiopathic normal pressure hydrocephalus. Furthermore, physiologic process such as sleep facilitates the glymphatic clearance, thus clearing accumulation of protein deposition, such as amyloid or tau, potentially delaying the progression of neurodegenerative diseases.

Summary: The glymphatic system plays a crucial role in clearing metabolic wastes in the brain. Glymphatic MR imaging using GBCA administration serves as a functional imaging tool to measure the glymphatic function and investigate various pathophysiologies of neurodegenerative diseases.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain / diagnostic imaging
  • Contrast Media* / metabolism
  • Gadolinium / metabolism
  • Humans
  • Magnetic Resonance Imaging / methods
  • Neurodegenerative Diseases* / diagnostic imaging
  • Neurodegenerative Diseases* / metabolism
  • Sleep

Substances

  • Contrast Media
  • Gadolinium